Filter Results:
(998)
Show Results For
- All HBS Web
(998)
- News (153)
- Research (694)
- Events (23)
- Multimedia (1)
- Faculty Publications (435)
Show Results For
- All HBS Web
(998)
- News (153)
- Research (694)
- Events (23)
- Multimedia (1)
- Faculty Publications (435)
- 01 Apr 2000
- News
Getting the Message
Global Internet Practice. He previously served as founder and CEO of an interactive brand marketing consultancy, where he developed patented applications to help corporations build relationships between their brands and their customers in... View Details
Keywords: Susan Young
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
firms face little competition, even after the end of formal periods of patent protection and market exclusivity. Additionally, the evolving technologies of drug development—in particular, the increasingly common use of auxiliary endpoints... View Details
Keywords: Dina Gerdeman
- 01 Dec 2007
- News
Lighten Up
improve stability on trails. The company now holds patents on the technology. It was an innovative product in search of a brand. “Is this really a Timberland idea, we asked ourselves,” Smith recalls. “Timberland is all about leather and... View Details
- April 2024 (Revised July 2024)
- Case
Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs
By: Joseph L. Badaracco, Tom Quinn and John Schultz
Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details
Keywords: Cost vs Benefits; Decisions; Judgments; Values and Beliefs; Global Strategy; Health Care and Treatment; Patents; Growth and Development Strategy; Growth Management; Product Positioning; Supply and Industry; Supply Chain; Corporate Social Responsibility and Impact; Mission and Purpose; Philanthropy and Charitable Giving; Opportunities; Social Issues; Equality and Inequality; Pharmaceutical Industry; Health Industry; Denmark; United States; Europe; China; India; Middle East; North Africa
Badaracco, Joseph L., Tom Quinn, and John Schultz. "Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs." Harvard Business School Case 324-114, April 2024. (Revised July 2024.)
- 22 Jan 2019
- First Look
New Research and Ideas, January 22, 2019
majority of patents (especially in manufacturing). We also offer evidence that the suppliers’ conceptual attributes are higher for SC industries, which is consistent with their greater innovative activity. Finally, we find that employment... View Details
Keywords: Dina Gerdeman
- 17 Oct 2006
- First Look
First Look: October 17, 2006
by universities on sharing rather than patenting scientific discoveries; more cross-disciplinary academic research; and more federal and private funding for translational research, which bridges basic and applied science. With such... View Details
Keywords: Sean Silverthorne
- 23 Feb 2010
- First Look
First Look: Feb. 23
engineering (SE) employment and patenting by inventors with Indian and Chinese names in cities and firms dependent upon the program relative to their peers. Most specifications find limited effects for native SE employment or patenting.... View Details
Keywords: Martha Lagace
- 01 May 2007
- First Look
First Look: May 1, 2007
face major challenges including headline-grabbing litigation, imminent patent expirations, new technologies, rising drug development costs, generic drug substitution, international competitors, and complex public policy issues. This case... View Details
Keywords: Sean Silverthorne
- 02 Oct 2015
- News
The ‘F’ Word
for Nourish, a patented line of spill-proof bottled water for infants and toddlers that we had already launched in airport shops and specialty stores. The product flew off the shelves. The national retailer and its distributor required... View Details
Keywords: Walt Disney Studios
- 07 Dec 2010
- First Look
First Look: Dec. 7
case:http://cb.hbsp.harvard.edu/cb/product/711417-PDF-ENG Plavix: Drugs in the Age of Personalized Medicine Richard G. Hamermesh, Mara G. Aspinall, and Rachel GordonHarvard Business School Note 811-001 PIavix, one of the world's best selling drugs in 2010, appears to... View Details
Keywords: Sean Silverthorne
- 29 Sep 2009
- First Look
First Look: September 29
inventions as the top 1% of U.S. inventions for a technology during 1975-1984 in terms of subsequent citations. Patenting growth is significantly higher in cities and technologies where breakthrough inventions occur after 1984 relative to... View Details
Keywords: Martha Lagace
- 13 Sep 2019
- News
Hollywood Ending
this or this,” she says, flipping between the two orientations. The technology to make this happen seamlessly is one that they’ve patented and among a half-dozen tech-based innovations they’re hoping will transform mobile storytelling. At... View Details
- 01 Dec 2013
- News
Curing Health Care
fundraising, IP, patent law, and the ins and outs of FDA and HIPAA regulations. Tecco and Gross refined their vision for Rock Health in a field study with HBS senior lecturer Bob Higgins. But first, Tecco had the experience of founding... View Details
- 27 Sep 2011
- First Look
First Look: September 27
Even in the absence of national health coverage, the United States became the world's largest prescription drug market and emerged as the global leader in new drug research and testing. With health benefits globally from the availability of new drugs, albeit for poorer... View Details
Keywords: Sean Silverthorne
- Web
Terms of Use | HBS Online
of Harvard Business School Online and/or its affiliates or licensors and is protected by copyright, patent and/or other proprietary intellectual property rights under United States and foreign law. Harvard Business School Online logos,... View Details
- Web
Print View - Course Catalog
PE – Part I Day 5: Complex Contracts: PE – Part II Day 6: Contracts – Earnout Provisions Module 2: Additional Building Blocks Day 7: Torts and Toxic Torts Day 8: IP – Patents and Patent Licenses Day 9: IP –... View Details
- Person Page
Media
Media
This lists media reports covering my firm dollarDEX Investments or me (or my colleagues), or columns written by me (or my colleagues). There are all... View Details